481 related articles for article (PubMed ID: 30200836)
1. Factor V Leiden G1691A, Prothrombin G20210A, and MTHFR C677T and A1298C Mutations in Patients With Sickle Cell Disease in Tunisia.
Belhaj Nefissi R; Doggui R; Ouali F; Messaoud T; Gritli N
Hemoglobin; 2018 Mar; 42(2):96-102. PubMed ID: 30200836
[TBL] [Abstract][Full Text] [Related]
2. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
3. Thrombophilic Mutations Among Patients with Sickle Cell Disease.
Nefissi RB; Ouali F; Massaoud T; Gritli N
Clin Lab; 2017 Nov; 63(11):1815-1818. PubMed ID: 29226645
[TBL] [Abstract][Full Text] [Related]
4. Screening for inherited thrombophilia might be warranted among Eastern Mediterranean sickle-beta-0 thalassemia patients.
Isma'eel H; Arnaout MS; Shamseddeen W; Mahfouz R; Zeineh N; Jradi O; Taher A
J Thromb Thrombolysis; 2006 Oct; 22(2):121-3. PubMed ID: 17008978
[TBL] [Abstract][Full Text] [Related]
5. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of factor V Leiden G1691A, MTHFR C677T, and prothrombin G20210A among Asian Indian sickle cell patients.
Pandey SK; Meena A; Kishor K; Mishra RM; Pandey S; Saxena R
Clin Appl Thromb Hemost; 2012 Jun; 18(3):320-3. PubMed ID: 22084413
[TBL] [Abstract][Full Text] [Related]
7. Thrombophilic mutations among Southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.
Rahimi Z; Vaisi-Raygani A; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Jun; 25(3):288-92. PubMed ID: 17619828
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of factor V G1691A (Leiden), prothrombin G20210A, and methylene tetrahydrofolate reductase C677T thrombophilic mutations in children with inflammatory bowel disease.
Kader HA; Berman WF; Al-Seraihy AS; Ware RE; Ulshen MH; Treem WR
J Pediatr Gastroenterol Nutr; 2002 Nov; 35(5):629-35. PubMed ID: 12454577
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Factor V Leiden, Prothrombin G20210A, MTHFR C677T and MTHFR A1298C gene polymorphisms in retinopathy of prematurity in a Turkish cohort.
Aydin H; Gunay M; Celik G; Gunay BO; Aydin UT; Karaman A
Ophthalmic Genet; 2016 Dec; 37(4):415-418. PubMed ID: 27018927
[TBL] [Abstract][Full Text] [Related]
10. MTHFR (C677T, A1298C), FV Leiden polymorphisms, and the prothrombin G20210A mutation in arterial ischemic stroke among young tunisian adults.
M'barek L; Sakka S; Meghdiche F; Turki D; Maalla K; Dammak M; Kallel C; Mhiri C
Metab Brain Dis; 2021 Mar; 36(3):421-428. PubMed ID: 33400068
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of thrombotic risk factors among beta-thalassemia patients from Western Iran.
Rahimi Z; Ghaderi M; Nagel RL; Muniz A
J Thromb Thrombolysis; 2008 Dec; 26(3):229-33. PubMed ID: 17982733
[TBL] [Abstract][Full Text] [Related]
12. Risk Factors of Thrombophilia-Related Mutations for Early and Late Pregnancy Loss.
Borsi E; Potre O; Ionita I; Samfireag M; Secosan C; Potre C
Medicina (Kaunas); 2024 Mar; 60(4):. PubMed ID: 38674167
[No Abstract] [Full Text] [Related]
13. The prevalence of factor V Leiden (G1691A), prothrombin G20210A and methylenetetrahydrofolate reductase C677T mutations in Jordanian patients with beta-thalassemia major.
Al-Sweedan SA; Jaradat S; Iraqi M; Beshtawi M
Blood Coagul Fibrinolysis; 2009 Dec; 20(8):675-8. PubMed ID: 19710606
[TBL] [Abstract][Full Text] [Related]
14. Factor V Leiden G1691A, prothrombin G20210A, and MTHFR C677T mutations in Turkish inflammatory bowel disease patients.
Yasa MH; Bolaman Z; Yukselen V; Kadikoylu G; Karaoglul AO; Batun S
Hepatogastroenterology; 2007; 54(77):1438-42. PubMed ID: 17708272
[TBL] [Abstract][Full Text] [Related]
15. Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.
Mueller T; Marschon R; Dieplinger B; Haidinger D; Gegenhuber A; Poelz W; Webersinke G; Haltmayer M
J Vasc Surg; 2005 May; 41(5):808-15. PubMed ID: 15886665
[TBL] [Abstract][Full Text] [Related]
16. The clinical impact of MTHFR polymorphism on the vascular complications of sickle cell disease.
Moreira Neto F; Lourenço DM; Noguti MA; Morelli VM; Gil IC; Beltrão AC; Figueiredo MS
Braz J Med Biol Res; 2006 Oct; 39(10):1291-5. PubMed ID: 16906320
[TBL] [Abstract][Full Text] [Related]
17. Factor V G1691A, prothrombin G20210A, and methylenetetrahydrofolate reductase [MTHFR] C677T gene polymorphism in angiographically documented coronary artery disease.
Almawi WY; Ameen G; Tamim H; Finan RR; Irani-Hakime N
J Thromb Thrombolysis; 2004 Jun; 17(3):199-205. PubMed ID: 15353918
[TBL] [Abstract][Full Text] [Related]
18. Primary thrombophilia in Mexico. II. Factor V G1691A (Leiden), prothrombin G20210A, and methylenetetrahydrofolate reductase C677T polymorphism in thrombophilic Mexican mestizos.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ramírez-Cisneros FJ
Am J Hematol; 2001 Jan; 66(1):28-31. PubMed ID: 11426488
[TBL] [Abstract][Full Text] [Related]
19. Factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations among patients with sickle cell disease in Eastern Saudi Arabia.
Fawaz NA; Bashawery L; Al-Sheikh I; Qatari A; Al-Othman SS; Almawi WY
Am J Hematol; 2004 Jul; 76(3):307-9. PubMed ID: 15224376
[TBL] [Abstract][Full Text] [Related]
20. Thrombophilic genes alterations as risk factor for recurrent pregnancy loss.
Farahmand K; Totonchi M; Hashemi M; Reyhani Sabet F; Kalantari H; Gourabi H; Mohseni Meybodi A
J Matern Fetal Neonatal Med; 2016; 29(8):1269-73. PubMed ID: 26135458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]